KLRA · Kailera Therapeutics Inc. Common Stock

this person other insiders at KLRA

Insiders & Stakes

BAIN CAPITAL INVESTORS LLC Director	▲ Buy	Open Market	26,255,581 Shares held	4/20/2026	View profile
Andrew T. Kaplan	▲ Buy	Open Market	26,255,581 Shares held	4/20/2026	View profile
Bain Capital Life Sciences Investors, LLC 10% Owner	▲ Buy	Open Market	22,583,268 Shares held	4/20/2026	View profile
Adam Koppel	▲ Buy	Open Market	22,583,268 Shares held	4/20/2026	View profile
RTW INVESTMENTS, LP Director	▲ Buy	Open Market	10,776,820 Shares held	4/20/2026	View profile
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% Owner	▼ Sell	Other	2,034,133 Shares held	4/20/2026	View profile
Ronald C. Renaud Jr. CEO & President	▲ Buy	Option Exercise	38,094 Shares held	6/9/2026	View profile

Ronald C. Renaud Jr.	▲ Buy	Option Exercise	38,094	$200K	6/9/2026
RTW INVESTMENTS, LP	▼ Sell	Other	10,276,820	—	4/20/2026
RTW INVESTMENTS, LP	▲ Buy	Open Market	500,000	$8.0M	4/20/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	▼ Sell	Other	9,477,719	—	4/20/2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	▼ Sell	Other	2,034,133	—	4/20/2026
BAIN CAPITAL INVESTORS LLC	▼ Sell	Other	17,857,143	—	4/20/2026
BAIN CAPITAL INVESTORS LLC	▲ Buy	Open Market	8,398,438	$134.4M	4/20/2026
Adam Koppel	▼ Sell	Other	16,875,000	—	4/20/2026
Adam Koppel	▼ Sell	Other	4,145,768	—	4/20/2026
Adam Koppel	▲ Buy	Open Market	1,562,500	$25.0M	4/20/2026
Bain Capital Life Sciences Investors, LLC	▼ Sell	Other	16,875,000	—	4/20/2026
Bain Capital Life Sciences Investors, LLC	▼ Sell	Other	4,145,768	—	4/20/2026
Bain Capital Life Sciences Investors, LLC	▲ Buy	Open Market	1,562,500	$25.0M	4/20/2026
Andrew T. Kaplan	▼ Sell	Other	17,857,143	—	4/20/2026
Andrew T. Kaplan	▲ Buy	Open Market	8,398,438	$134.4M	4/20/2026